Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Würtz, Morten
67  Ergebnisse:
Personensuche X
?
1

Net clinical benefit of extended dual pathway inhibition ac..:

Würtz, Morten ; Olesen, Kevin Kris Warnakula ; Bhatt, Deepak L...
European Heart Journal - Cardiovascular Pharmacotherapy.  10 (2024)  3 - p. 201-209 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Effectiveness and Safety of Ticagrelor Implementation in Pa..:

Thrane, Pernille Gro ; Olesen, Kevin Kris Warnakula ; Würtz, Morten...
The Lancet Regional Health - Europe.  14 (2022)  - p. 100301 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Antithrombotic treatment beyond 1 year after percutaneous c..:

Jensen, Thomas ; Thrane, Pernille G ; Olesen, Kevin K W...
European Heart Journal - Cardiovascular Pharmacotherapy.  9 (2022)  3 - p. 208-219 , 2022
Link: https://doi.org/10.1093/..
 
?
4

Insulin-treated versus noninsulin-treated diabetes and risk..:

Jensen, Thomas ; Olesen, Kevin Kris Warnakula ; De Caterina, Raffaele...
Vascular Pharmacology.  136 (2021)  - p. 106809 , 2021
Link: https://doi.org/10.1016/..
 
?
5

CHA2DS2‐VASc impact on risk following percutaneous coronary..:

Jensen, Thomas ; Thrane, Pernille Gro ; Olesen, Kevin Kris Warnakula...
European Journal of Clinical Investigation.  52 (2021)  4 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
6

Thirteen-year trends in cardiovascular risk in men and wome..:

Olesen, Kevin Kris Warnakula ; Jensen, Esben Skov ; Gyldenkerne, Christine...
European Heart Journal - Quality of Care and Clinical Outcomes.  8 (2021)  4 - p. 437-446 , 2021
Link: https://doi.org/10.1093/..
 
?
7

Dual antithrombotic treatment in chronic coronary syndrome:..:

Würtz, Morten ; Olesen, Kevin Kris Warnakula ; Mortensen, Martin Bødtker...
European Heart Journal.  43 (2021)  10 - p. 996-1004 , 2021
Link: https://doi.org/10.1093/..
 
?
8

Comorbidity and risk of venous thromboembolism after hospit..:

Würtz, Morten ; Grove, Erik Lerkevang ; Corraini, Priscila...
Journal of Thrombosis and Haemostasis.  18 (2020)  8 - p. 1974-1985 , 2020
Link: https://doi.org/10.1111/..
 
?
9

Diabetes is not a risk factor for myocardial infarction in ..:

Gyldenkerne, Christine ; Olesen, Kevin KW ; Thrane, Pernille G...
Diabetes and Vascular Disease Research.  17 (2020)  4 - p. 147916412094180 , 2020
Link: https://doi.org/10.1177/..
 
?
10

Cardiovascular risks associated with smoking in patients wi..:

Olesen, Kevin Kris Warnakula ; Thrane, Pernille Gro ; Würtz, Morten..
European Journal of Preventive Cardiology.  29 (2020)  1 - p. e14-e17 , 2020
Link: https://doi.org/10.1093/..
 
?
11

A Novel Model for Prediction of Thromboembolic and Cardiova..:

Steensig, Kamilla ; Olesen, Kevin K W ; Madsen, Morten...
The American Journal of Cardiology.  131 (2020)  - p. 40-48 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Risk of Myocardial Infarction in Patients Without Angiograp..:

Olesen, Kevin KW ; Madsen, Morten ; Würtz, Morten...
The American Journal of Cardiology.  132 (2020)  - p. 8-14 , 2020
Link: https://doi.org/10.1016/..
 
?
13

The ABO locus is associated with increased platelet aggrega..:

Christiansen, Morten Krogh ; Larsen, Sanne Bøjet ; Nyegaard, Mette...
International Journal of Cardiology.  286 (2019)  - p. 152-158 , 2019
Link: https://doi.org/10.1016/..
 
?
14

External applicability of the COMPASS trial: the Western De..:

Würtz, Morten ; Olesen, Kevin Kris Warnakula ; Thim, Troels...
European Heart Journal - Cardiovascular Pharmacotherapy.  5 (2019)  4 - p. 192-199 , 2019
Link: https://doi.org/10.1093/..
 
?
15

Pre-admission use of platelet inhibitors and short-term str..:

Würtz, Morten ; Schmidt, Morten ; Grove, Erik Lerkevang...
European Heart Journal - Cardiovascular Pharmacotherapy.  4 (2018)  3 - p. 158-165 , 2018
Link: https://doi.org/10.1093/..
 
1-15